Adult obesity in the United States has gone up over the past 30 years. Here's a look at why.

Researchers reviewed the body mass index of over 11 million Americans.

America’s obesity problem is tipping the scales. A new study found that the share of US adults living with obesity has more ...

The novel metabolic predictor emphasizes central adiposity, while integrating metabolites and other measures of metabolic ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

By Gnaneshwar Rajan and Sriparna Roy Jan 30 (Reuters) - Regeneron Pharmaceuticals' executives voiced confidence in its ...

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

A renowned physician-scientist says treatment is not one-size-fits-all.

BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...

Mid-stage trial data showed Roche's experimental shot delivered weight loss on par with leading obesity treatments, ...